Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, described markets as "fragile," citing sentiment and presidential influence. She highlighted Royalty Pharma as a resilient biopharma investment.
11 hours Ago
Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, described markets as "fragile," citing sentiment and presidential influence. She highlighted Royalty Pharma as a resilient biopharma investment..
Revenue Falls 7.4%, Sales and profit slip as boycotts weigh ...
